UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up

Annals of oncology, 2019-06, Vol.30 (6), p.970-976

2019

Volltextzugriff (PDF)

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

The New England journal of medicine, 2017-03, Vol.376 (11), p.1015-1026

2017

Volltextzugriff (PDF)

Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up

Annals of oncology, 2023-03, Vol.34 (3), p.289-299

2023

Volltextzugriff (PDF)

512MO Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: An analysis of the IGCCCG Update database

Annals of oncology, 2022-09, Vol.33, p.S777

2022

Volltextzugriff (PDF)

1747P Impact of prior chemotherapy (Chemo) on pembrolizumab (Pembro) response in urothelial cancer (UC): Exploratory analysis of the phase III KEYNOTE-045 study

Annals of oncology, 2022-09, Vol.33, p.S1336-S1337

2022

Volltextzugriff (PDF)

Three-year follow-up from the phase III KEYNOTE-045 trial: Pembrolizumab (Pembro) versus investigator’s choice (paclitaxel, docetaxel, or vinflunine) in recurrent, advanced urothelial cancer (UC)

Annals of oncology, 2019-10, Vol.30, p.v366-v367

2019

Volltextzugriff (PDF)

919P - Three-year follow-up from the phase III KEYNOTE-045 trial: Pembrolizumab (Pembro) versus investigator’s choice (paclitaxel, docetaxel, or vinflunine) in recurrent, advanced urothelial cancer (UC)

Annals of oncology, 2019-10, Vol.30, p.v366-v367

2019

Volltextzugriff (PDF)

Impact of prognostic factors and risk groups on overall survival (OS) in patients treated with pembrolizumab vs investigator’s choice chemotherapy for advanced urothelial cancer (UC): Post hoc analysis of KEYNOTE-045

Annals of oncology, 2018-10, Vol.29, p.viii320-viii321

2018

Volltextzugriff (PDF)

Subgroup analyses from KEYNOTE-045: Pembrolizumab (pembro) versus individual investigator’s choice of chemotherapy (paclitaxel, docetaxel, or vinflunine) in recurrent, advanced urothelial cancer (uc)

Annals of oncology, 2017-09, Vol.28, p.v298-v298

2017

Volltextzugriff (PDF)

Pembrolizumab (pembro) versus paclitaxel, docetaxel, or vinflunine for recurrent, advanced urothelial cancer (UC): Mature results from the phase 3 KEYNOTE-045 trial

Annals of oncology, 2017-09, Vol.28, p.v623-v623

2017

Volltextzugriff (PDF)

Sleep and daily functioning during androgen deprivation therapy for prostate cancer

European journal of cancer care, 2011-07, Vol.20 (4), p.549-554

2011

Volltextzugriff (PDF)

4534 POSTER Phase II study of single-agent vinflunine in platinum-refractory transitional cell carcinoma of the urothelium (TCCU)

European journal of cancer supplements, 2007, Vol.5 (4), p.309-309

2007

Volltextzugriff (PDF)

Paclitaxel and carboplatin in bladder cancer

European journal of cancer (1990), 2000-07, Vol.36, p.7-12

Vaughn, D.J.

2000

Volltextzugriff (PDF)

Sleep and daily functioning during androgen deprivation therapy for prostate cancer: Sleep during androgen deprivation therapy

European journal of cancer care, 2011-07, Vol.20 (4), p.549-554

2011

Volltextzugriff (PDF)

Paclitaxel and carboplatin in bladder cancer: recent developments

European journal of cancer (1990), 2000-07, Vol.36, p.7-12

Vaughn, D.J.

2000

Volltextzugriff (PDF)

208 Patterns of failure and impact of adjuvant therapy following pancreaticoduodenectomy for ampullary carcinomas

International journal of radiation oncology, biology, physics, 1999, Vol.45 (3), p.257-257

1999

Volltextzugriff (PDF)

A pilot study of early hospital discharge in adult patients with fever and neutropenia

European journal of cancer (1990), 1994, Vol.30A (10), p.1595-1596

1994

Volltextzugriff (PDF)

Sulfur Dioxide Standards: Primary More Restrictive Than Secondary?

Journal of the Air Pollution Control Association, 1973-12, Vol.23 (12), p.1039-1041

1973

Volltextzugriff (PDF)

INSPIRE: A Phase 3 Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of LIQ861 in Pulmonary Arterial Hypertension (PAH) (Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil NCT03399604)

The Journal of heart and lung transplantation, 2019-04, Vol.38 (4), p.S11-S11

2019

Volltextzugriff (PDF)

Transparent optical protection ring architectures and applications

Journal of lightwave technology, 2005-10, Vol.23 (10), p.3388-3403

2005

Volltextzugriff (PDF)

Family-based association of FKBP5 in bipolar disorder

Molecular psychiatry, 2009-03, Vol.14 (3), p.261-268

2009

Volltextzugriff (PDF)

OPERA: an optical packet experimental routing architecture with label swapping capability

Journal of lightwave technology, 1998-12, Vol.16 (12), p.2135-2145

1998

Volltextzugriff (PDF)

Milk Thistle Extracts Inhibit the Oxidation of Low-Density Lipoprotein (LDL) and Subsequent Scavenger Receptor-Dependent Monocyte Adhesion

Journal of agricultural and food chemistry, 2008-06, Vol.56 (11), p.3966-3972

2008

Volltextzugriff (PDF)

Effect of Albizia julibrissin Water Extracts on Low-Density Lipoprotein Oxidization

Journal of agricultural and food chemistry, 2007-06, Vol.55 (12), p.4704-4709

2007

Volltextzugriff (PDF)

A rapid estimation procedure for within-tree populations of red oak borer (Coleoptera: Cerambycidae)

Forest ecology and management, 2005-08, Vol.215 (1), p.163-168

2005

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(38)
Tagungsberichte
(5)

Sprache

Englisch
(43)

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Life Sciences & Biomedicine
(17)
Humans
(11)
Physical Sciences
(7)
Biological And Medical Sciences
(6)
Technology
(6)
Engineering
(5)
Engineering, Electrical & Electronic
(5)
Oncology
(5)
Payloads
(5)
Animals
(4)
Baseband
(4)
Fundamental And Applied Biological Sciences. Psychology
(4)
Optical Wavelength Conversion
(4)
Optics
(4)
Plant Extracts - Pharmacology
(4)
Adult
(3)
Aged
(3)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Middle Aged
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up

512MO Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: An analysis of the IGCCCG Update database

1747P Impact of prior chemotherapy (Chemo) on pembrolizumab (Pembro) response in urothelial cancer (UC): Exploratory analysis of the phase III KEYNOTE-045 study

Three-year follow-up from the phase III KEYNOTE-045 trial: Pembrolizumab (Pembro) versus investigator’s choice (paclitaxel, docetaxel, or vinflunine) in recurrent, advanced urothelial cancer (UC)

919P - Three-year follow-up from the phase III KEYNOTE-045 trial: Pembrolizumab (Pembro) versus investigator’s choice (paclitaxel, docetaxel, or vinflunine) in recurrent, advanced urothelial cancer (UC)

Impact of prognostic factors and risk groups on overall survival (OS) in patients treated with pembrolizumab vs investigator’s choice chemotherapy for advanced urothelial cancer (UC): Post hoc analysis of KEYNOTE-045

Subgroup analyses from KEYNOTE-045: Pembrolizumab (pembro) versus individual investigator’s choice of chemotherapy (paclitaxel, docetaxel, or vinflunine) in recurrent, advanced urothelial cancer (uc)

Pembrolizumab (pembro) versus paclitaxel, docetaxel, or vinflunine for recurrent, advanced urothelial cancer (UC): Mature results from the phase 3 KEYNOTE-045 trial

Sleep and daily functioning during androgen deprivation therapy for prostate cancer

4534 POSTER Phase II study of single-agent vinflunine in platinum-refractory transitional cell carcinoma of the urothelium (TCCU)

Paclitaxel and carboplatin in bladder cancer

Sleep and daily functioning during androgen deprivation therapy for prostate cancer: Sleep during androgen deprivation therapy

Paclitaxel and carboplatin in bladder cancer: recent developments

208 Patterns of failure and impact of adjuvant therapy following pancreaticoduodenectomy for ampullary carcinomas

A pilot study of early hospital discharge in adult patients with fever and neutropenia

Sulfur Dioxide Standards: Primary More Restrictive Than Secondary?

INSPIRE: A Phase 3 Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of LIQ861 in Pulmonary Arterial Hypertension (PAH) (Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil NCT03399604)

Transparent optical protection ring architectures and applications

Family-based association of FKBP5 in bipolar disorder

OPERA: an optical packet experimental routing architecture with label swapping capability

Milk Thistle Extracts Inhibit the Oxidation of Low-Density Lipoprotein (LDL) and Subsequent Scavenger Receptor-Dependent Monocyte Adhesion

Effect of Albizia julibrissin Water Extracts on Low-Density Lipoprotein Oxidization

A rapid estimation procedure for within-tree populations of red oak borer (Coleoptera: Cerambycidae)

Suchergebnisse filtern